Risk factors of non-Hodgkin's lymphoma

Bibliography

• Eltom MA, Jemal A, Mbulaiteye SM, Trends in kaposi's sarcoma and Non-Hodgkin's lymphoma incidence in the united states from 1973 through 1998. J Natl Cancer Inst 2002;5:1204-10
   Google Scholar
• Howlader N, Noone AM, Krapcho M, SEER Cancer Statistics Review, 1975 – 2008. National Cancer Institute, Bethesda, MD; based on November 2010 SEER data submission.
   Google Scholar
• Aisenberg AC. Historical review of lymphomas. Br J Haematol 2000;109:466-76
   PubMed Web of Science ®Google Scholar
• Cogliatti SB, Schmid U. Who is WHO and what was REAL? Swiss Med Wkly 2002;132:607-17
   PubMedGoogle Scholar
• Jaffe ES, Harris NL, Stein H, Organization classification of tumours/pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press; Lyon, France: 2001
   Google Scholar
• Morton LM, Wang SS, Devesa SS, Lymphoma incidence patterns by who subtype in the United States, 1992 – 2001. Blood 2006;107:265-76
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Cozen W, Etiologic heterogeneity among Non-Hodgkin Lymphoma subtypes. Blood 2008;15:5150-60
   Web of Science ®Google Scholar
• Hartge P, Wang SS, Bracci PM, Non-Hodgkin Lymphoma. In: Schottenfeld D, Fraumeni JFJ. editors. Cancer epidemiology and prevention. Oxford University Press; New York: 2006. p. 898-918
   Google Scholar
• Morton LM, Hartge P, Holford TR, Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the international lymphoma epidemiology consortium (InterLymph). Cancer Epidemiol Biomarkers Prev 2005;14:925-33
   PubMed Web of Science ®Google Scholar
• Morton LM, Zheng T, Holford TR, Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005;6:469-76
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sanjose SD, Bracci PM, Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol 2008;167:1321-31
   PubMed Web of Science ®Google Scholar
• Hughes AM, Armstrong BK, Vajdic CM, Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004;112:865-71
   PubMed Web of Science ®Google Scholar
• Smedby KE, Hjalgrim H, Melbye M, Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005;97:199-209
   PubMed Web of Science ®Google Scholar
• Zhang Y, Holford TR, Leaderer B, Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2007;165:1255-64
   PubMed Web of Science ®Google Scholar
• Kricker A, Amstrong BK, Hughes AM, Personal sun exposure and risk of non-Hodgkin lymphoma: a pooled analysis form the InterLymph Consortium. Int J Cancer 2008;122:144-54
   PubMed Web of Science ®Google Scholar
• Willett EV, Morton LM, Hartge P, Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 2008;122:2062-70
   PubMed Web of Science ®Google Scholar
• Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer 2011; [Epub ahead of print]
   Google Scholar
• Dryver E, Brandt L, Kauppinen T, Occupational exposures and non-Hodgkin's lymphoma in Southern Sweden. Int J Occup Environ Health 2004;10:13-21
   PubMed Web of Science ®Google Scholar
• Kato I, Koenig KL, Watanabe-Meserve H, Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States). Cancer Causes Control 2005;16:1215-24
   PubMed Web of Science ®Google Scholar
• Fritschi L, Benke G, Hughes AM, Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia). Cancer Causes Control 2005;16:599-607
   PubMed Web of Science ®Google Scholar
• Vineis P, Miligi L, SenioriCostantini A. Exposure to solvents and risk of non-Hodgkin lymphoma: clues on putative mechanisms. Cancer Epidemiol Biomarkers Prev 2007;16:381-4
   PubMed Web of Science ®Google Scholar
• Miligi L, Costantini AS, Benvenuti A, Occupational exposure to solvents and the risk of lymphomas. Epidemiology 2006;17:552-61
   PubMed Web of Science ®Google Scholar
• Cocco P, t'Mannetje A, Fadda D, Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study. Occup Environ Med 2010;67:341-7
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang Y, Lan Q, Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol 2009;169:176-85
   PubMed Web of Science ®Google Scholar
• Viel JF, Floret N, Deconinck E, Increased risk of non-Hodgkin lymphoma and serum organochlorine concentrations among neighbors of a municipal solid waste incinerator. Environ Int 2011;37:449-53
   PubMed Web of Science ®Google Scholar
• Bertrand KA, Spiegelman D, Aster JC, Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men. Epidemiology 2010;21:172-80
   PubMed Web of Science ®Google Scholar
• Laden F, Bertrand KA, Altshul L, Plasma organochlorine levels and risk of non-Hodgkin lymphoma in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 2010;19:1381-4
   PubMed Web of Science ®Google Scholar
• Cocco P, Brennan P, Ibba A, Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes. Occup Environ Med 2008;65:132-40
   PubMed Web of Science ®Google Scholar
• Chang ET, Balter LM, Torrang A, Nutrient intake and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2006;164:1222-32
   PubMed Web of Science ®Google Scholar
• Zheng T, Holford TR, Leaderer B, Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 2004;159:454-66
   PubMed Web of Science ®Google Scholar
• Lim U, Wang SS, Hartge P, Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 2007;109:3050-9
   PubMed Web of Science ®Google Scholar
• Skibola CF, Nieters A, Bracci PM, A functional tnfrsf5 gene variant is associated with risk of lymphoma. Blood 2008;111:4348-54
   PubMed Web of Science ®Google Scholar
• Lan Q, Zheng T, Chanock S, Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 2007;28:823-7
   PubMed Web of Science ®Google Scholar
• Lan Q, Zheng T, Shen M, Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet 2007;121:161-8
   PubMed Web of Science ®Google Scholar
• Rothman N, Skibola CF, Wang SS, Genetic variation in tnf and il10 and risk of non-Hodgkin lymphoma: a report from the Interlymph consortium. Lancet Oncol 2006;7:27-38
   PubMed Web of Science ®Google Scholar
• Nieters A, Beckmann L, Deeg E, Gene polymorphisms in toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 2006;7:615-24
   PubMed Web of Science ®Google Scholar
• Purdue MP, Lan Q, Wang SS, A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 2009;30:275-81
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Ansell SM, Fredericksen ZS, Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007;110:4455-63
   PubMed Web of Science ®Google Scholar
• Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001;11:173-86
   PubMed Web of Science ®Google Scholar
• Lightfoot TJ, Skibola CF, Smith AG, Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica 2006;91:1222-7
   PubMed Web of Science ®Google Scholar
• Chaganti RS, Nanjangud G, Schmidt H, Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. Semin Hematol 2000;37:396-411
   PubMed Web of Science ®Google Scholar
• Shen M, Purdue MP, Kricker A, Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica 2007;92:1180-5
   PubMed Web of Science ®Google Scholar
• Nauss KM, Newberne PM. Effects of dietary folate, vitamin b12 and methionine/choline deficiency on immune function. Adv Exp Med Biol 1981;135:63-91
   PubMed Web of Science ®Google Scholar
• Kim HN, Lee IK, Kim YK, Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008;140:287-94
   PubMed Web of Science ®Google Scholar
• Conde L, Halperin E, Akers NK, Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010;42:661-4
   PubMed Web of Science ®Google Scholar
• Smedby KE, Foo JN, Skibola CF, GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet 2011;7:e1001378
   PubMed Web of Science ®Google Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993;329:987-94
   PubMed Web of Science ®Google Scholar
• Battaglioli T, Gorini G, Costantini AS, Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin's lymphoma: a population-based study. Ann Oncol 2006;17:1283-9
   PubMed Web of Science ®Google Scholar
• Geyer SM, Morton SM, Habermann TM, Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer 2010;116:2993-3000
   PubMed Web of Science ®Google Scholar
• Talamini R, Polesel J, Spina M, The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma. Int J Cancer 2008;122:1624-9
   PubMed Web of Science ®Google Scholar
• Bell DA, Liu Y, Cortopassi GA. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 1995;87:223-4
   PubMed Web of Science ®Google Scholar
• Lo coco F, Gaidano G, Louie DC, P53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993;82:2289-95
   PubMed Web of Science ®Google Scholar
• Han X, Zheng T, Foss FM, Alcohol consumption and non-Hodgkin lymphoma survival. J Cancer Surviv 2010;4:101-9
   PubMedGoogle Scholar
• Diaz LE, Montero A, Gonzalez-gross M, Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 2002;56(Suppl 3):s50-3
   PubMed Web of Science ®Google Scholar
• Tarella C, Caracciolo D, Gavarotti P, Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant 2000;26:1185-91
   PubMed Web of Science ®Google Scholar
• El-Far M, Fouda M, Yahya R, El-Baz H. Serum il-10 and il-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma. J Physiol Biochem 2004;60:253-8
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, Distinct types of diffuse large b-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11
   PubMed Web of Science ®Google Scholar
• Lossos IS, Alizadeh AA, Rajapaksa R, Hgal is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large b-cell lymphoma. Blood 2003;101:433-40
   PubMed Web of Science ®Google Scholar
• Lossos IS, Jones CD, Warnke R, Expression of a single gene, bcl-6, strongly predicts survival in patients with diffuse large b-cell lymphoma. Blood 2001;98:945-51
   PubMed Web of Science ®Google Scholar
• Shipp MA, Ross KN, Tamayo P, Diffuse large b-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002;8:68-74
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wight G, Chan WC, The use of molecular profiling to predict survival after chemotherapy for diffuse large-b-cell lymphoma. N Engl J Med 2002;346:1937-47
   PubMed Web of Science ®Google Scholar
• Horsman DE, Connors JM, Pantzar T, Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001;30:375-82
   PubMed Web of Science ®Google Scholar
• Yunis JJ, Frizzera G, Oken MM, Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 1987;316:79-84
   PubMed Web of Science ®Google Scholar
• Eray M, Postila V, Eeva J, Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre b cells. Scand J Immunol 2003;57:545-55
   PubMed Web of Science ®Google Scholar
• Bohen SP, Troyanskaya OG, Alter O, Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci USA 2003;100:1926-30
   PubMed Web of Science ®Google Scholar
• De Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005;23:6358-63
   PubMed Web of Science ®Google Scholar
• Lech-Maranda E, Baseggio L, Bienvenu J, Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large b-cell lymphoma. Blood 2004;103:3529-34
   PubMed Web of Science ®Google Scholar
• Berglund M, Thunberg U, Roos G, The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large b-cell lymphoma. Blood 2005;105:4894-5
   PubMed Web of Science ®Google Scholar
• Domingo-Domenech E, Benavente Y, Gonzalez-Barca E, Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms. Haematologica 2007;92:1475-81
   PubMed Web of Science ®Google Scholar
• Kube D, Hua TD, Kloss M, The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma. Genes Immun 2007;8:164-7
   PubMed Web of Science ®Google Scholar
• Lee JJ, Kim DH, Lee NY, Interleukin-10 gene polymorphism influences the prognosis of t-cell non-Hodgkin lymphomas. Br J Haematol 2007;137:329-36
   PubMed Web of Science ®Google Scholar
• Warzocha K, Ribeiro P, Bienvenu J, Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998;91:3574-81
   PubMed Web of Science ®Google Scholar
• Seidemann K, Zimmermann M, Book M, Tumor necrosis factor and lymphotoxinalfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster trial nhl-bfm 95. J Clin Oncol 2005;23:8414-21
   PubMed Web of Science ®Google Scholar
• Juszczynski P, Kalinka E, Bienvenu J, Human leukocyte antigens class ii and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 2002;100:3037-40
   PubMed Web of Science ®Google Scholar
• Nowak J, Kalinka-Warzocha E, Juszczynski P, Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 2007;46:500-7
   PubMed Web of Science ®Google Scholar
• Fitzgibbon J, Grenzelias D, Matthews J, Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Haematol 1999;107:388-91
   PubMed Web of Science ®Google Scholar
• Gemmati D, Ongaro A, Tognazzo S, Methylenetetrahydrofolatereductase c677t and a1298c gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival. Haematologica 2007;92:478-85
   PubMed Web of Science ®Google Scholar
• Hohaus S, Mansueto G, Massini G, Glutathione-s-transferase genotypes influence prognosis in follicular non-Hodgkin's lymphoma. Leuk Lymphoma 2007;48:564-9
   PubMed Web of Science ®Google Scholar
• Hu LL, Wang XX, Chen X, Bcrp gene polymorphisms are associated with susceptibility and survival of diffuse large b-cell lymphoma. Carcinogenesis 2007;28:1740-4
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Wang S, Maurer MJ, Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007;109:5439-46
   PubMed Web of Science ®Google Scholar
• Han X, Zheng T, Foss FM, Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival. Am J Hematol 2010;85:51-6
   PubMed Web of Science ®Google Scholar
• Armitage P, Berry G, Mathews JNS. Statistical methods in medical research. Wiley-Blackwell; 2001
   Google Scholar
• Orsborne C, Byers R. Impact of gene expression profiling in lymphoma diagnosis and prognosis. Histopathology 2011;58:106-27
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lan Q, Rothman N, A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. JNCI 2005;97:1616-18
   PubMed Web of Science ®Google Scholar
• MacCuish JD, MacCuish NE. Clustering in bioinformatics and drug discovery. Chapman and Hall/CRC; 2010
   Google Scholar
• Monti S, Savage KL, Kutok JL, Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005;105:1851-61
   PubMed Web of Science ®Google Scholar
• Ma S, Song X. Ranking prognosis markers in cancer genomic studies. Brief Bioinform 2011;12:33-40
   PubMed Web of Science ®Google Scholar
• Storey JD. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 2003;31:2013-35
   Web of Science ®Google Scholar
• Ma S, Huang J, Shi M, Semiparametric prognosis models in genomic studies. Brief Bioinform 2010;11:385-93
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Wiestner A, The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-97
   PubMed Web of Science ®Google Scholar
• Ma S, Huang J. Penalized feature selection and classification in bioinformatics. Brief Bioinform 2008;9:392-403
   PubMed Web of Science ®Google Scholar
• Ma S, Zhang Y, Huang J, Identification of Non-Hodgkin's lymphoma prognosis signatures using the CTGDR method. Bioinformatics 2010;26:15-21
   PubMed Web of Science ®Google Scholar
• Han X, Li Y, Huang J, Identification of predictive pathways for non-Hodgkin lymphoma prognosis. Cancer Inform 2010;9:281-92
   PubMedGoogle Scholar
• Peng G, Luo L, Siu H, Gene and pathway-based second-wave analysis of genome-wide association studies. Eur J Hum Genet 2010;18:111-17
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genome wide association studies. Am J Hum Genet 2007;81:1278-83
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 2005;102:15545-50
   PubMed Web of Science ®Google Scholar
• Efron B, Tibshirani R. On testing the significance of sets of genes. Ann Appl Stat 2007;1:107-29
   Web of Science ®Google Scholar
• Goeman JJ, van de Geer S, de Kort F, A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004;20:93-9
   PubMed Web of Science ®Google Scholar
• Ma S, Shi M, Li Y, Incorporating gene co-expression network in identification of cancer prognosis markers. BMC Bioinformatics 2010;11:271
   PubMed Web of Science ®Google Scholar
• Ma S, Kosorok MR, Huang J, Incorporating higher-order representative features improves prediction in network-based cancer prognosis analysis. BMC Med Genomics 2011;4:5
   PubMedGoogle Scholar